Alexander Lauten

Showing 1-9 of 9 articles

A randomised comparison of monoplane versus biplane fluoroscopy in patients undergoing percutaneous coronary intervention: the RAMBO trial

Leistner D, Schlender L, Steiner J, Erbay A, Klotsche J, Schauerte P, Haghikia A, Rauch-Kröhnert U, Sinning D, Lauten A, Mochmann H, Skurk C, Landmesser U, Stähli B

October 23, 2020 | 10.4244/EIJ-D-20-00217

Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a randomised controlled trial

Dreger H, Mattig I, Hewing B, Knebel F, Lauten A, Lembcke A, Thoenes M, Roehle R, Stangl V, Landmesser U, Grubitzsch H, Stangl K, Laule M

April 17, 2020 | 10.4244/EIJ-D-19-00901

The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Paitazoglou C, Özdemir R, Pfister R, Bergmann M, Bartunek J, Kilic T, Lauten A, Schmeisser A, Zoghi M, Anker S, Sievert H, Mahfoud F

August 29, 2019 | 10.4244/EIJ-D-19-00342

The Experts “Live” Workshop of the EuroCTO Club 2017, Berlin

Bufe A, Di Mario C, Landmesser U, Gessner M, Sianos G, Garbo R, Dini C, Lauer B, Boudou N, Grancini L, Avran A, Lauten A, Mashayekhi K, Hildick-Smith D, Escaned J, Buettner H, Reifart N, Lapp H, Galassi A, Werner G

April 20, 2018 | 10.4244/EIJV13I17A324

Interventions for heart failure

PERKAT RV: first in vivo data of a novel right heart assist device

Kretzschmar D, Lauten A, Schubert H, Bischoff S, Schulze PC, Ferrari M

April 6, 2018 | 10.4244/EIJ-D-17-00899

Interventions for valvular disease

Impact of concomitant mitral regurgitation on transvalvular gradient and flow in severe aortic stenosis: a systematic ex vivo analysis of a subentity of low-flow low-gradient aortic stenosis

Katte F, Franz M, Jung C, Figulla H, Leistner D, Jakob P, Stähli B, Kretzschmar D, Lauten A, Figulla H

February 20, 2018 | 10.4244/EIJ-D-17-00476

Interventions for valvular disease

Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve

Figulla H, Kiss K, Lauten A

September 18, 2016 | 10.4244/EIJV12SYA32

Interventions for valvular disease

Tricuspid valve interventions in 2015

Lauten A, Figulla HR

September 17, 2015 | 10.4244/EIJV11SWA37

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

Lauten A, Figulla HR, Möllmann H, Holzhey D, Kotting J, Beckmann A, Veit C, Cremer J, Kuck K, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr F, Hamm C

November 20, 2014 | 10.4244/EIJV10I7A145

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...